"We will be funding the original grantees for the next year under the previous criteria [set by the Obama administration]," a spokesperson for the U.S. Department of Health and Human Services told the Hill.
Trending Sexual Health
- Biology, Funding, and Ego Slow Quest for Male Birth Control
- Trump Administration Will Continue Teen Pregnancy Prevention Program After All
- Why Is This Insurance Company Denying Coverage to Patients Trying to Reduce Their Chances of Contracting HIV?
- Health Researchers Quietly Tackle the Opioid Epidemic’s Hidden Crisis
- This Week in Sex: Essure Implant off U.S. Market; Endometriosis Drug Coming
- Will Second Time Be the Charm for ‘Female Viagra’ Pill Addyi?
After years and thousands of complaints about the implant Essure, Bayer finally takes it off shelves. And the first new endometriosis treatment in a decade brings hope of pain relief.
Why Is This Insurance Company Denying Coverage to Patients Trying to Reduce Their Chances of Contracting HIV?
A new lawsuit in Massachusetts seeks to change that.
After conflicts between its makers, the drug is back with a cheaper price tag and a new way to get it. Yet questions persist about whether it's necessary and whether it works.
These programs are trying to bridge the gap between drug treatment and sexual and reproductive health—an ambitious goal with little precedent.
The anti-choice group promises to use the $8 million in taxpayer funds to target Texas women "most likely to obtain an abortion.”